2007
DOI: 10.1016/j.vetpar.2007.08.046
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of sarcoptic mange in dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0
34

Year Published

2008
2008
2022
2022

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(45 citation statements)
references
References 7 publications
0
11
0
34
Order By: Relevance
“…In dogs fitted with an imidacloprid/flumethrin collar, the parasitological cure was reported after 3 months in a laboratory study [ 24 ]. In several studies, either no control group was included [ 14 , 24 ] or a positive control product was used [ 13 ]. In the laboratory studies that used placebo-treated [ 21 ] or untreated control animals [ 15 ], a decrease in mite counts was reported in the control animals during the study period.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In dogs fitted with an imidacloprid/flumethrin collar, the parasitological cure was reported after 3 months in a laboratory study [ 24 ]. In several studies, either no control group was included [ 14 , 24 ] or a positive control product was used [ 13 ]. In the laboratory studies that used placebo-treated [ 21 ] or untreated control animals [ 15 ], a decrease in mite counts was reported in the control animals during the study period.…”
Section: Discussionmentioning
confidence: 99%
“…There are various topical and systemic therapies currently used for the treatment of sarcoptic mange in dogs [ 4 , 7 ], either by contact activity onto the skin (e.g. amitraz dips; fipronil spray, metaflumizone/amitraz spot-on formulation, imidacloprid/flumethrin collar; or fipronil/amitraz/S-methoprene spot-on formulation) [ 6 , 8 , 14 , 15 , 16 , 19 , 20 , 24 ], or through systemic activity (e.g. selamectin and moxidectin/imidacloprid spot-on formulation having transcutaneous absorption) [ 13 , 17 , 21 , 23 , 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…Currently available licensed therapeutic options for sarcoptic mange may include the active compounds selamectin [ 12 ], imidacloprid/moxidectin [ 13 ] and in some countries amitraz [ 14 ], which are administered topically. A recent therapeutic option in some areas is oral treatment with the isoxazoline sarolaner.…”
Section: Introductionmentioning
confidence: 99%
“…Systemically acting macrocyclic lactones, such as ivermectin, milbemycin oxime, moxidectin, and selamectin, have been used successfully for control of canine sarcoptic mange. Efficacy of such treatments (based on mite counts and/or clinical signs) can vary considerably ranging from 60% to 100% (Fourie et al 2007). Furthermore, with the exception of selamectin, these drugs are not licensed for the treatment of sarcoptic mange.…”
Section: Resultsmentioning
confidence: 99%